Details for New Drug Application (NDA): 218253
✉ Email this page to a colleague
NDA 218253 describes AMIODARONE HYDROCHLORIDE, which is a drug marketed by Acella, Bedford, Bedford Labs, Ben Venue, Dr Reddys, Epic Pharma Llc, Eugia Pharma, Fresenius Kabi Usa, Gland Pharma Ltd, Hikma Farmaceutica, Hospira, Intl Medication Sys, Mylan Institutional, Par Sterile Products, Zhejiang Poly Pharm, Aurobindo Pharma Ltd, Chartwell Rx, Dr Reddys Labs Sa, Pharmobedient, Rubicon Research, Taro, Teva, Teva Pharms, Unichem, Upsher Smith Labs, and Zydus Pharms Usa Inc, and is included in thirty-one NDAs. It is available from thirty-four suppliers. Additional details are available on the AMIODARONE HYDROCHLORIDE profile page.
The generic ingredient in AMIODARONE HYDROCHLORIDE is amiodarone hydrochloride. There are fifteen drug master file entries for this compound. Thirty-seven suppliers are listed for this compound. Additional details are available on the amiodarone hydrochloride profile page.
The generic ingredient in AMIODARONE HYDROCHLORIDE is amiodarone hydrochloride. There are fifteen drug master file entries for this compound. Thirty-seven suppliers are listed for this compound. Additional details are available on the amiodarone hydrochloride profile page.
Summary for 218253
| Tradename: | AMIODARONE HYDROCHLORIDE |
| Applicant: | Zhejiang Poly Pharm |
| Ingredient: | amiodarone hydrochloride |
| Patents: | 0 |
Suppliers and Packaging for NDA: 218253
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| AMIODARONE HYDROCHLORIDE | amiodarone hydrochloride | INJECTABLE;INJECTION | 218253 | ANDA | Hainan Poly Pharm. Co., Ltd. | 14335-430 | 14335-430-10 | 3 mL in 1 VIAL, GLASS (14335-430-10) |
| AMIODARONE HYDROCHLORIDE | amiodarone hydrochloride | INJECTABLE;INJECTION | 218253 | ANDA | Hainan Poly Pharm. Co., Ltd. | 14335-431 | 14335-431-10 | 9 mL in 1 VIAL, GLASS (14335-431-10) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 50MG/ML | ||||
| Approval Date: | Sep 11, 2024 | TE: | AP | RLD: | No | ||||
Complete Access Available with Subscription
